Reactive perforating collagenosis
ICD-10 L87.1 is a billable code used to indicate a diagnosis of reactive perforating collagenosis.
Reactive perforating collagenosis (RPC) is a rare skin disorder characterized by the transepidermal elimination of collagen fibers, leading to the formation of small, itchy papules that can ulcerate and crust over. Clinically, RPC presents as dome-shaped papules, often located on the extensor surfaces of the limbs, particularly in individuals with underlying conditions such as diabetes mellitus or chronic renal failure. The lesions may be triggered by trauma or friction, and they typically resolve with scarring. The condition is thought to involve a dysregulation of collagen metabolism and may be associated with systemic diseases. Diagnosis is primarily clinical, supported by a thorough patient history and physical examination. Skin biopsy may be performed to confirm the diagnosis, revealing collagen fibers within the epidermis. Disease progression can vary, with some patients experiencing recurrent lesions while others may have a more chronic course. Understanding the underlying causes and potential triggers is crucial for effective management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L87.1 specifically covers reactive perforating collagenosis, which may occur in patients with diabetes, chronic renal disease, or other systemic conditions. It is characterized by the elimination of collagen through the epidermis, leading to distinctive skin lesions.
L87.1 should be used when the diagnosis of reactive perforating collagenosis is confirmed, particularly when lesions are present and associated with underlying systemic conditions. It should not be used for other perforating disorders without specific clinical features.
Documentation for L87.1 should include a detailed clinical history, physical examination findings, and any relevant laboratory or biopsy results that confirm the diagnosis of reactive perforating collagenosis.
